UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Frontiers in immunology, 2020, Vol.11, p.580547-580547

2020

Volltextzugriff (PDF)

Phylogenetic analysis of porcine reproductive and respiratory syndrome virus isolates from Northern Ireland

Archives of virology, 2018-10, Vol.163 (10), p.2799-2804

2018

Volltextzugriff (PDF)

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Influenza and other respiratory viruses, 2015-07, Vol.9 (4), p.169-178

2015

Volltextzugriff (PDF)

Genomic Analysis and Surveillance of Respiratory Syncytial Virus (RSV) Using Wastewater-Based Epidemiology (WBE)

The Journal of infectious diseases, 2024-04

2024

Volltextzugriff (PDF)

Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium

American journal of respiratory and critical care medicine, 2013-10, Vol.188 (7), p.842-851

2013

Volltextzugriff (PDF)

In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs)

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1442, p.119

2016

Volltextzugriff (PDF)

Safety and Immunogenicity of a Novel Recombinant Subunit Respiratory Syncytial Virus Vaccine (BBG2Na) in Healthy Young Adults

The Journal of infectious diseases, 2001-12, Vol.184 (11), p.1456-1460

2001

Volltextzugriff (PDF)

Protective Levels of Polysaccharide-Specific Maternal Antibodies May Enhance the Immune Response Elicited by Pneumococcal Conjugates in Neonatal and Infant Mice

Infection and Immunity, 2005-02, Vol.73 (2), p.956-964

2005

Volltextzugriff (PDF)

Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria

Infection and Immunity, 2004-01, Vol.72 (1), p.187-195

2004

Volltextzugriff (PDF)

Protective Efficacy against Respiratory Syncytial Virus following Murine Neonatal Immunization with BBG2Na Vaccine: Influence of Adjuvants and Maternal Antibodies

The Journal of infectious diseases, 1999-06, Vol.179 (6), p.1326-1333

1999

Volltextzugriff (PDF)

Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide

The Journal of infectious diseases, 1997-09, Vol.176 (3), p.560-569

1997

Volltextzugriff (PDF)

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine

Vaccine, 2001-07, Vol.19 (30), p.4143-4152

2001

Volltextzugriff (PDF)

Respiratory syncytial virus (RSV) vaccines : Two steps back for one leap forward: Respiratory viruses

Journal of clinical virology, 2008, Vol.41 (1), p.38-44

POWER, Ultan F

2008

Volltextzugriff (PDF)

Protective Immunity against Respiratory Syncytial Virus in Early Life after Murine Maternal or Neonatal Vaccination with the Recombinant G Fusion Protein BBG2Na

The Journal of infectious diseases, 1997-10, Vol.176 (4), p.884-891

1997

Volltextzugriff (PDF)

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen

FEMS immunology and medical microbiology, 2000, Vol.29 (4), p.247-253

2000

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection

Phylogenetic analysis of porcine reproductive and respiratory syndrome virus isolates from Northern Ireland

Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials

Genomic Analysis and Surveillance of Respiratory Syncytial Virus (RSV) Using Wastewater-Based Epidemiology (WBE)

Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium

In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs)

Safety and Immunogenicity of a Novel Recombinant Subunit Respiratory Syncytial Virus Vaccine (BBG2Na) in Healthy Young Adults

Protective Levels of Polysaccharide-Specific Maternal Antibodies May Enhance the Immune Response Elicited by Pneumococcal Conjugates in Neonatal and Infant Mice

Immunization of Female Mice with Glycoconjugates Protects Their Offspring against Encapsulated Bacteria

Protective Efficacy against Respiratory Syncytial Virus following Murine Neonatal Immunization with BBG2Na Vaccine: Influence of Adjuvants and Maternal Antibodies

Challenge of BALB/c Mice with Respiratory Syncytial Virus Does Not Enhance the Th2 Pathway Induced after Immunization with a Recombinant G Fusion Protein, BBG2NA, in Aluminum Hydroxide

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccine

Respiratory syncytial virus (RSV) vaccines : Two steps back for one leap forward: Respiratory viruses

Protective Immunity against Respiratory Syncytial Virus in Early Life after Murine Maternal or Neonatal Vaccination with the Recombinant G Fusion Protein BBG2Na

Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen

Aktive Filter

Suchergebnisse filtern